• About
  • Masthead
  • License Content
  • Advertise
  • Submit Press Release
  • RSS/Email List
  • Write for us
  • Contact us
2 Minute Medicine
No Result
View All Result

No products in the cart.

SUBSCRIBE
  • Specialties
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • Wellness
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Visual
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • AccountLog-in/out
    • Subscribe
    • Sign-in
    • My account
2 Minute Medicine
  • Specialties
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • Wellness
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Visual
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • AccountLog-in/out
    • Subscribe
    • Sign-in
    • My account
SUBSCRIBE
2 Minute Medicine
Subscribe
Home All Specialties Chronic Disease

Quick Take: Discovery and validation of a prognostic proteomic signature for tuberculosis progression

byAliya Ramjaun
April 25, 2019
in Chronic Disease, Infectious Disease, Preclinical, Public Health, Pulmonology
Reading Time: 2 mins read
0
Share on FacebookShare on Twitter

RELATED REPORTS

#VisualAbstract: Non-severe tuberculosis in children can be treated with a shorter 4-month regimen instead of 6-month regimen

Non-severe tuberculosis in children can be treated with a shorter 4-month regimen

Biomarkers demonstrate neuroprognostic accuracy for patients with hypoxic ischemic brain injury following cardiac arrest

Tuberculosis (TB) is the leading cause of death by an infectious disease. Identifying affected individuals, particularly if they are asymptomatic, however, remains a challenge as the infectious organisms are primarily contained within lung granulomas and/or draining lymph nodes. Biomarkers in the host’s blood compartment may be used in identifying individuals that are progressing from M. tuberculosis infection or latent disease, to active TB disease. In this longitudinal cohort study, 6,363 M. tuberculosis-infected, HIV-negative South African adolescents age 12 to 18 years who participated in the Adolescent Cohort Study (ACS, 2005-2007) were followed up for 2 years to identify proteomic biomarkers of TB progression, with the aim of developing a non-sputum, blood-based, point-of-care diagnostic. Researchers found that 46 individuals developed microbiologically confirmed TB disease within 2 years of follow-up. These participants were selected as progressors; 106 non-progressors, who remained healthy, were matched to the progressors. Using a highly multiplexed proteomic assay (SOMAscan), 3,000 human proteins were quantified in plasma. Of these, 361 proteins were of differential abundance between the progressors and non-progressors. A 5-protein signature, TB Risk Model 5 (TRM5), was discovered in the ACS training set and verified by blind prediction in the ACS test set. Poor performance on samples 13-24 months before TB diagnosis motivated discovery of a second 3-protein signature, 3-protein pair-ratio (3PR). The prognostic performance of both signatures was subsequently validated in an independent cohort of 1,948 HIV-negative household TB contacts from The Gambia, a small West African country, where individuals age 15 to 60 years were followed up for 2 years, sampled at baseline, month 6, and month 18. Researchers found that the prognostic performance of the TRM5 signature in the ACS training set was excellent within 6 months of TB diagnosis (AUC 0.96, 95% CI 0.93 to 0.99) and 6-12 months (AUC 0.76, 95% CI 0.65 to 0.87) before TB diagnosis. In the Gambian validation cohort, TRM5 validated with an AUC of 0.66 (95% CI 0.56 to 0.75) within 1 year of TB diagnosis, while the 3PR signature yielded an AUC of 0.89 (95% CI 0.84 to 0.95) within 6 months of TB diagnosis and 0.72 (95% CI 0.64 to 0.81) 7-12 months before TB diagnosis in the entire South African discovery cohort and validated with an AUC of 0.65 (95% CI 0.55 to 0.75) within 1 year of TB diagnosis in the Gambian validation cohort. This study therefore shows that proteomic biomarkers such as TRM5 and 3PR may play a role in predicting progression to incident TB. Further validation, particularly in cohorts from non-African countries, is necessary in determining the utility of these proteomic biomarkers in other affected populations.

Click to read the study in PLOS Medicine 

Image: PD

©2019 2 Minute Medicine, Inc. All rights reserved. No works may be reproduced without expressed written consent from 2 Minute Medicine, Inc. Inquire about licensing here. No article should be construed as medical advice and is not intended as such by the authors or by 2 Minute Medicine, Inc.

Tags: 3PRbiomarkersproteomicsTRM5tuberculosis
Previous Post

Increased sedentary activity across all age groups in the United States

Next Post

Quick Take: Intimate Partner Homicide of Adolescents

RelatedReports

#VisualAbstract: COVID-19 vaccines provided durable protection from COVID-19, but their effectiveness waned over time in North Carolina
StudyGraphics

#VisualAbstract: Non-severe tuberculosis in children can be treated with a shorter 4-month regimen instead of 6-month regimen

April 13, 2022
Updated review confirms efficacy and safety of most standard treatments for latent tuberculosis infection
Chronic Disease

Non-severe tuberculosis in children can be treated with a shorter 4-month regimen

March 16, 2022
Quick Take: Efficacy of prehospital criteria in identifying trauma patients susceptible to undertriage
Cardiology

Biomarkers demonstrate neuroprognostic accuracy for patients with hypoxic ischemic brain injury following cardiac arrest

April 7, 2022
#VisualAbstract: Rifapentine-moxifloxacin noninferior to standard of care treatment for pulmonary tuberculosis
StudyGraphics

#VisualAbstract: Rifapentine-moxifloxacin noninferior to standard of care treatment for pulmonary tuberculosis

May 18, 2021
Next Post
Quick Take: Intimate Partner Homicide of Adolescents

Quick Take: Intimate Partner Homicide of Adolescents

Amniotic fluid lactate associated with labor disorders

Medicaid expansion associated with improved relative racial disparities in birth outcomes

Parental nonmedical prescription opioid use linked to adolescent use

Nutrients from food, not supplements, linked to lower risks of death, cancer

License Our Award-Winning Physician-Written Medical News and Visual Abstracts

2 Minute Medicine is the leading authoritative medical news licensing service, and the only with reports written by practicing doctors.

LICENSE CONTENT

Get 2MM+ Premium Access

No ads & unlimited access to all current reports, over 9000 searchable archived reports, visual abstracts, Weekly Rewinds, and the online edition of The Classics Series™ textbook.

Subscription Options
2 Minute Medicine

2 Minute Medicine® is an award winning, physician-run, expert medical media company. Our content is curated, written and edited by practicing health professionals who have clinical and scientific expertise in their field of reporting. Our editorial management team is comprised of highly-trained MD physicians. Join numerous brands, companies, and hospitals who trust our licensed content.

Recent Reports

  • #VisualAbstract: Severe actinic keratosis and need for additional treatment are markers for an increased risk of cutaneous squamous cell carcinoma
  • Virtual yoga and meditation intervention may be associated with increased health-related quality of life
  • Wellness Check: Mental Health
License Content
Terms of Use | Disclaimer
Cookie Policy
Privacy Statement (EU)
Disclaimer

© 2021 2 Minute Medicine, Inc. - Physician-written medical news.

  • Specialties
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • Wellness
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Visual
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • Account
    • Subscribe
    • Sign-in
    • My account

© 2021 2 Minute Medicine, Inc. - Physician-written medical news.